MitoAction meeting discussing multiple specialists.
To work or not to work...that is the question Many adults with mitochondrial disease face a difficult decision about how to financially support themselves...
Join us for an informative webinar exploring KYGEVVI™ (doxecitine and doxribtimine), the first FDA-approved treatment for thymidine kinase 2 deficiency (TK2d) in adults and...
Join MitoAction and Annette Hines on April 3, 2020 for our April Monthly Mito Expert Series. Ins and Outs of Social Security Navigating Supplemental...